VIM
RPRX icon

Vinva Investment Management’s Royalty Pharma RPRX Stock Holding History

Vinva Investment Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,057
Closed -$860K – 490
2025
Q4 		$860K Buy
+22,057
New +$841K 0.01% 313
2025
Q2 		– Sell
-12,050
Closed -$378K – 438
2025
Q1 		$378K Sell
12,050
-5,048
-30% -$160K 0.02% 339
2024
Q4 		$433K Sell
17,098
-2,848
-14% -$75.5K 0.02% 357
2024
Q3 		$563K Sell
19,946
-3,647
-15% -$101K 0.02% 361
2024
Q2 		$629K Buy
23,593
+11,627
+97% +$322K 0.03% 338
2024
Q1 		$363K Buy
+11,966
New +$353K 0.02% 388

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vinva Investment Management's RPRX Position: Q1 2026 in Review

Vinva Investment Management sold out of Royalty Pharma (RPRX) in Q1 2026, closing a stake of 22,057 shares — an estimated $860K sold.

Vinva Investment Management first reported a position in RPRX in Q1 2024 and held it in 6 quarters. The position peaked at $860K in Q4 2025. 590 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Vinva Investment Management reported no remaining Royalty Pharma position as of Q1 2026 after selling out during the quarter.
  • Vinva Investment Management sold 22,057 Royalty Pharma shares in Q1 2026, an estimated $860K.
  • Vinva Investment Management first reported a position in Royalty Pharma in Q1 2024 and held it in 6 quarters.
  • Vinva Investment Management's Royalty Pharma position peaked at $860K in Q4 2025.
  • 590 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.